Home
    Registration
    Accommodation
    Invitation Letter
    Contact Us
     Home
     Welcome Note
     Congress Chairpersons
     Scientific Committee
     Faculty
     Scientific Program
     Timetable
     CME
     Young Investigators Posters
         Submission Guidelines
         Poster Presentation Guidelines
         Award Ceremony
         Poster Texts
     Registration
         Invitation Letter
     Sponsors
     Sponsorship & Exhibition
     Accommodation
         Hotel Rey Juan Carlos
         Hotel Senator Barcelona
     General Information
         Before you travel...
         Transportation
         Italian Agent
         Tips and Hints
     About Barcelona
     Partners
  
1st World Congress on
Controversies in the Management of Viral Hepatitis (C-Hep)
Palau de Congressos de Catalunya, Barcelona, Spain, 19-22 May, 2011
 
  Hans L. Tillmann Print
Hans L. Tillmann

Hans L. Tillmann has gained a reputation for developing innovative but sometimes controversial ideas, some of which lead to unexpected discoveries; he was instrumental in discovering GBV-C’s positive influence on HIV infection and identification of anti-GB E2 antibodies’ role in prohibiting GBV-C infection as well as discovering lamivudine resistant HBV strains not only resistant to but dependent on lamivudine.
 
His interest in viral hepatitis in the setting of organ transplant was accompanied by his engagement to establish a complete prevention of HBV-reinfection by direct antivirals plus HBIg, and more recently attempts to substitute HBIg by vaccine approaches or combination antivirals. He has a more than a decade experience in running a diagnostic laboratory for viral load determination.
 
After completing medical school in Mainz, Germany, Hans Tillmann trained and worked for Michael Manns in Hannover, Germany for 11 years. In Hannover he was responsible for the viral hepatitis diagnostic laboratory, which led to numerous high ranking publications including in the Lancet, the New England Journal of Medicine, Gastroenterology and others. 
 
In 2004 he was appointed Professor of Medicine in Leipzig, Germany and continued to focus on viral infections. In 2007 he joined the Duke Clinical Research Institute (DCRI), which can be considered the largest academic clinical research institution worldwide, where is now is responsible for viral load and safety monitoring for various clinical trials. He has an interest in treatment prediction and optimized use of antivirals.
 
HLT has published over 120 original and 65 review and opinion articles, and 35 book chapters, and has edited 2 books.

Home    Contact Us   
 
Copyright © 2007 comtecmed.com. All rights reserved.   The website was last updated on 10/16/2011 Created by     WebStudio.co.il